Emerald Coast Research Group

2857 Royal Isle Drive

Tallahassee, FL  32312

Ph. (850) 415-0251   Fax (850) 415-6462

Medical Director:  Dean Watson, M.D.

 

 

Year

Phase

Disease

Protocol

Contract

Enrolled

Investigators/

Coordinators

1999- Oct. 2001

Completed

 

Hypertension

Omapatrilat Hypertension Trial in Subjects Uncontrolled on Calcium Channel Blocker Therapy

 

 

Sub. – Greg Sloan, MD

Coord. – K. Schroeder

1999- Oct. 2001

Completed

 

Hypertension

Omapatrilat Hypertension Trial in Subjects uncontrolled on Ace Inhibitor Therapy

 

 

 

2000-2001

Completed

 

Cardiovascular

PRINCE Trial-Pravastatin Inflammation/CRP Evaluation in Primary and Secondary Prevention in Cardiovascular Events

 

 

PI – Greg Sloan, MD

Coord. – K. Schroeder

2000- ongoing

 III

Type II Diabetes

 

 

 

PI – Greg Sloan, MD

Sub. – Lisa Clark, MD

Sub. – Patrick Conrad, MD

Coord. – K. Schroeder

Coord. – T. Martin

Mar.  2001-

Completed

III

Type II Diabetes

DepoMed

 

 

PI – Greg Sloan, MD

Cood. – K. Schroeder

Coord. – T. Martin

 

Aug. 2001-Oct. 2002

Completed

IIb

Hypertension

Aventis

 

 

PI – Greg Sloan, MD

Coord. – K. Schroeder

Coord. – T. Martin

Aug. 2001-

Completed

IIb

Hypertension

Bristol-Myers Squibb

OCTAVE

 

 

PI – Greg Sloan, MD

Coord.-K. Schroeder

Nov. 2001- ongoing

III

Type II Diabetes

Bristol-Myers Squibb

 

 

PI – Greg Sloan, MD

Coord. – K. Schroeder

Coord. – T. Martin

Sept. 2002 – ongoing

III

Cardiovascular

Sanofi-Synthelabo: CHARISMA – Plavix vs. ASA,

 Atherothrombotic Prevention study

 

75

PI – Greg Sloan, MD

Sub. – Patrick Conrad, MD

Sub. – Lisa Clark, MD

Sub.- Wayne Campbell, MD

Coord. – K. Schroeder

Coord. – Tracy Martin

Mar. 2000-June 2000

IV 

Hypertension

LOGIC trial – Hypertension study with Lotrel

 

 

PI – Greg Sloan, MD

Sub.- Wayne Campbell, MD

Sub. – Lisa Clark, MD

Sub. – Patrick Conrad, MD

Coord. – K. Schroeder

April 2003- ongoing

III

Type II Diabetes

Bristol-Myers Squibb CV168-021

Study drug in Combination with Glyburide Therapy in Subjects with Type II DM Who Have Inadequate Glycemic Control on Sulfonylurea Therapy Alone

 

 

PI – Greg Sloan, MD

Sub. – Karl Hempel, MD

Sub. – Gary Winchester, MD

Sub.-Hugh VanLandingham, MD

Sub.-Lisa Clark, MD

Sub.-Patrick Conrad, MD

Sub.-Jason Griffin, MD

Coord. – K. Schroeder

Coord.- T. Martin

Coord. – Tara

Coord. – D. Williams

Coord.- K. Krasinski

Coord.- H. Barrentine

April 2003 – ongoing

III

Type II Diabetes

Bristol-Myers Squibb CV168-022

Study drug in Combination with Metformin Therapy in Subjects with Type II DM Who Have Inadequate Glycemic Control on Metformin Therapy Alone

 

 

PI – Greg Sloan, MD

Sub. – Karl Hempel, MD

Sub. – Gary Winchester, MD

Sub.-Hugh VanLandingham, MD

Sub.-Lisa Clark, MD

Sub.-Patrick Conrad, MD

Sub.-Jason Griffin, MD

Coord. – K. Schroeder

Coord.- T. Martin

Coord. – Tara

Coord. – D. Williams

Coord.- K. Krasinski

Coord.- H. Barrentine

Dec. 2003 – ongoing

 

 

 

 

 

 

 

 

IV

Erectile Dysfunction

Bayer

REALISE

 

 

PI – Karl Hempel, MD

PI – Gary Winchester, MD

PI -Hugh VanLandingham, MD

PI – Tomas Serio, MD

PI – Les Wilson, MD

PI – Michelle Stevens, MD

Coord. - Tara

Coord. – K. Krasinski

Sept 2003- onging

 

 

 

 

 

 

III

Type II Diabetes

BMS CV168-018

 

 

PI-Dr. Sloan

Sub-Dr. Stevens

Sub- Dr. Erwin-Wilson

Nov. 2003 – ongoing

 

 

 

 

III

Type II Diabetes

Bristol-Myers Squibb CV168-025

Study drug vs. Pioglitazone in Combination with Metformin Therapy in Subjects with Type II DM Who Have Inadequate Glycemic Control on Metformin Therapy Alone

 

 

 

PI- Dr.Sloan

Sub- Dr. Hempel

Sub- Dr. Winchester

Sub- Dr. VanLandingham

2004-ongoing

 

Hypertension

Novartis

 

 

PI-Dr. Fox

PI-Dr. Wilson

PI-Dr. Banks

PI-Dr. Campbell

 

2004-ongoing

 

Type II Diabetes

Novartis

 

 

PI-Dr. Hempel

PI-Dr. Clark

PI-Dr. Stevens

PI-Dr. Dorman

PI-Dr. Fulmer

PI-Dr. Wilson

PI-Dr. Sloan

PI-Dr. Campbell

2004-ongoing

 

 

 

 

 

 

 

Type II Diabetes

BMS CV168-048

 

 

         PI-Dr. Clark

PI-Dr. Wilson

2004-ongoing

 

 

Prostate Cancer

GlaxoSmithKline

 

 

PI-Dr. Sloan

PI-Dr. Banks

PI-Dr. Wilson

 

 

2004-ongoing

 

Dyspepsia

Novartis

 

 

PI-Dr. Clark

PI-Dr. Dorman

PI-Dr. Banks

PI-Dr. Campbell

PI-Dr. Stevens

PI-Dr. Sloan

PI-Dr. Fulmer

PI-Dr. Fox

PI-Dr. VanLandingham

PI-Dr. Wilson

2004-ongoing

 

 

 

 

Overactive Bladder

Pfizer

 

 

PI-Dr. Sloan

2004-ongoing

 

 

 

 

 

Type II Diabetes

BMS CV177-008

 

 

PI-Dr. Sloan

PI-Dr. Clark

PI-Dr. Stevens

PI-Dr. Fox

2004-ongoing

 

 

 

 

 

 

 

 

 

Overactive Bladder

Pfizer

 

 

PI-Dr. Clark

PI-Dr. Stevens

PI-Dr. Fox

PI-Dr. Erwin-Wilson

PI-Dr. Sloan